{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:51:03Z","timestamp":1780415463905,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.canep.2024.102552","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:38:30Z","timestamp":1709703510000},"page":"102552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study."],"prefix":"10.1016","volume":"90","author":[{"given":"Chris R.","family":"Cardwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Busby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9968-5991","authenticated-orcid":false,"given":"Peter","family":"Murchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canep.2024.102552_bib1","first-page":"582","article-title":"Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet","volume":"2020","author":"GBD","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2024.102552_bib2","doi-asserted-by":"crossref","unstructured":"Morgan E., Soerjomataram I., Gavin A.T., et al. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut 2021;70:234-242.","DOI":"10.1136\/gutjnl-2020-321089"},{"issue":"1","key":"10.1016\/j.canep.2024.102552_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12916-020-01891-5","article-title":"A systematic assessment of the association between frequently-prescribed medicines and the risk of common cancers: a series of nested case-control studies","volume":"19","author":"McDowell","year":"2021","journal-title":"BMC Med."},{"key":"10.1016\/j.canep.2024.102552_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(19)30246-3","article-title":"Advisory Group recommendations on priorities for the IARC Monographs","volume":"20","author":"IARC Monographs Priorities Group","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2024.102552_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1378\/chest.121.2.625","article-title":"Oral corticosteroids increase esophageal acid contact times in patients with stable asthma","volume":"121","author":"Lazenby","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.canep.2024.102552_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103508","article-title":"Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)","volume":"9","author":"Cook","year":"2014","journal-title":"PLOS One"},{"key":"10.1016\/j.canep.2024.102552_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00001648-200203000-00027","article-title":"Use of systemic corticosteroids and risk of esophageal cancer","volume":"13","author":"Sorensen","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.canep.2024.102552_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.mmcr.2012.02.003","article-title":"Association of esophageal candidiasis and squamous cell carcinoma","volume":"1","author":"Delsing","year":"2012","journal-title":"Med. Mycol. Case Rep."},{"key":"10.1016\/j.canep.2024.102552_bib9","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160474","article-title":"Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies","volume":"37","author":"Du","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.canep.2024.102552_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2007.05.022","article-title":"Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers","volume":"5","author":"Fortuny","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canep.2024.102552_bib11","series-title":"British National Formulary 80","author":"Joint Formulary Committee","year":"2020"},{"key":"10.1016\/j.canep.2024.102552_bib12","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jamainternmed.2017.5512","article-title":"Association of warfarin use with lower overall cancer incidence among patients older than 50 years","volume":"177","author":"Haaland","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.canep.2024.102552_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ctrv.2007.02.004","article-title":"The effect of anticoagulants on cancer risk and survival: systematic review","volume":"33","author":"Tagalakis","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.canep.2024.102552_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/pgmj.65.762.258","article-title":"Oesophageal ulcer caused by warfarin","volume":"65","author":"Loft","year":"1989","journal-title":"Post. Med. J."},{"key":"10.1016\/j.canep.2024.102552_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/joa3.12125","article-title":"Association of atrial fibrillation and gastroesophageal reflux disease: Natural and therapeutic linkage of the two common diseases","volume":"35","author":"Maruyama","year":"2019","journal-title":"J. Arrhythm."},{"key":"10.1016\/j.canep.2024.102552_bib16","first-page":"555","article-title":"Influence of common cardiac drugs on gastroesophageal reflux disease: multicenter questionnaire survey","volume":"49","author":"Nakaji","year":"2011","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.canep.2024.102552_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.canep.2024.102552_bib18","unstructured":"National statistics. (https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2015). Accessed Nov 2023."},{"key":"10.1016\/j.canep.2024.102552_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz076","article-title":"Data resource profile: national cancer registration dataset in England","volume":"49","author":"Henson","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.canep.2024.102552_bib20","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2024.102552_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3109\/00365521.2010.503968","article-title":"Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications","volume":"45","author":"Ladanchuk","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.canep.2024.102552_bib22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1572-0241.2006.00539.x","article-title":"Barrett's esophagus and medications that relax the lower esophageal sphincter","volume":"101","author":"Corley","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canep.2024.102552_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/apt.14416","article-title":"Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease","volume":"47","author":"Broers","year":"2018","journal-title":"Aliment Pharmacol. Ther."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782124000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:53:04Z","timestamp":1715946784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782124000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":23,"alternative-id":["S1877782124000316"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2024.102552","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study.","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2024.102552","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102552"}}